No Data
No Data
An Intrinsic Calculation For AtriCure, Inc. (NASDAQ:ATRC) Suggests It's 48% Undervalued
Key Insights AtriCure's estimated fair value is US$39.98 based on 2 Stage Free Cash Flow to Equity AtriCure is estimated to be 48% undervalued based on current share price of US$20.97 The US$47.3
Is AtriCure, Inc. (NASDAQ:ATRC) Trading At A 48% Discount?
Insider Buying: Chief Technical Officer Salvatore Privitera Acquires Shares of AtriCure Inc (ATRC)
AtriCure(ATRC.US) Officer Buys US$111.25K in Common Stock
$AtriCure(ATRC.US)$ Officer Privitera Salvatore purchased 5,000 shares of common stock on May 30, 2024 at an average price of $22.25 for a total value of $111.25K.Source: Announcement What is statemen
Analysts Offer Insights on Healthcare Companies: Atricure (ATRC), Immunovant (IMVT) and Monte Rosa Therapeutics (GLUE)
AtriCure to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference
AtriCure, Inc. ((